In this task, you're given a paragraph from the research paper and your task is to generate a suitable title for the research paper based on the given paper. Under 100 words is a good title length.

Q: This study shows that the disease free equilibrium ( ) for COVID-19 coronavirus does not satisfy the criteria for a locally or globally asymptotic stability. This implies that as a pandemic as declared by WHO (2020) the COVID-19 coronavirus does not have a curative vaccine yet and precautionary measures are advised through quarantine and observatory procedures. Also, the Basic Reproductive number ( 0 < 1) by Equation (33) shows that there is a chance of decline of secondary infections when the ratio between the incidence rate in the population and the total number of infected population quarantined with observatory procedure. The effort to evaluate the disease equilibrium shows that unless there is a dedicated effort from government, decision makers and stakeholders, the world would hardly be reed of the COVID-19 coronavirus and further spread is eminent and the rate of infection will continue to increase despite the increased rate of recovery because of the absence of vaccine at the moment.

A: MATHEMATICAL PREDICTIONS FOR COVID-19 AS A GLOBAL PANDEMIC
****
Q: Compared to classical epidemiologic methods, genomics can be used to precisely monitor virus evolution and transmission in real time across large, diverse populations. Integration of pathogen genomics with data about host genetics and global transcriptional responses to infection allows for comprehensive studies of population-level responses to infection and provides novel methods for predicting clinical outcomes. As genomic technologies become more accessible, these methods will redefine how emerging viruses are studied and outbreaks are contained. Here we review the existing and emerging genomic technologies that are enabling systems epidemiology and systems virology and making it possible to respond rapidly to emerging viruses such as Zika.

A: Genomic Signatures of Emerging Viruses: A New Era of Systems Epidemiology
****
Q: Objective: To examine pulmonary function, exercise capacity, and health-related quality of life (HRQoL) among severe acute respiratory syndrome (SARS) survivors. Methods: We evaluated survivors with confirmed SARS at the Prince of Wales Hospital, Hong Kong, at 3, 6, and 12 months after symptom onset. Our assessment included: lung volume (total lung capacity [TLC], vital capacity, residual volume, functional residual capacity), spirometry (FVC, FEV 1 ), diffusing capacity of the lung for carbon monoxide (DLCO), inspiratory and expiratory respiratory muscle strength, 6-min walk distance (6MWD), chest radiographs (CXRs), and HRQoL by Medical Outcomes Study 36-Item Short-Form General Health Survey questionnaire. Results: Ninety-seven patients completed the serial assessments. There were 39 male and 58 female patients, and 63 patients (70%) were health-care workers (mean age, 36.9 years [SD, 9.5 years]; body mass index, 23.7 kg/m 2 [SD, 4.0 kg/m 2 ]). At 1 year, 27 patients (27.8%) had abnormal CXR findings. Four patients (4.1%), 5 patients (5.2%), and 23 patients (23.7%) had FVC, TLC, and DLCO values < 80% of predicted values, respectively. The 6MWD at 12 months was 511.0 m (SD, 89.8 m), which was higher than at 3 months (mean difference, 47.0 m; 95% confidence interval [CI], 31.8 to 62.1 m; p < 0.01) but not different from 6 months (mean difference, 9.7 m; 95% CI, ؊ 4.4 to 23.8 m; p ‫؍‬ 0.18). The 6MWD was lower than that for normal control subjects of the same age groups, and there was impairment of HRQoL at 12 months. Patients who required ICU admission (n ‫؍‬ 31) showed higher CXR scores (1.6 [SD, 3.1]; vs 0.4 [SD, 1.1]; p ‫؍‬ 0.04) and lower percentage of predicted FVC, TLC, and DLCO than those who did not, but there were no differences in 6MWD and health status. Conclusion: Significant impairment in DLCO was noted in 23.7% of survivors 1 year after illness onset. Exercise capacity and health status of SARS survivors were remarkably lower than those of a normal population. (CHEST 2005; 128:2247-2261) Key words: severe acute respiratory syndrome; lung function; functional capacity; quality of life Abbreviations: ANOVA ϭ analysis of variance; BMI ϭ body mass index; BOOP ϭ bronchiolitis obliterans organizing pneumonia; BP ϭ bodily pain; CI ϭ confidence interval; CPET ϭ cardiopulmonary exercise testing; CRP ϭ C-reactive protein; CXR ϭ chest radiograph; Dlco ϭ diffusing capacity of the lung for carbon dioxide; FEF 25-75 ϭ forced expiratory flow, midexpiratory phase; FRC ϭ functional residual capacity; GH ϭ general health; HCW ϭ health-care worker; HK ϭ Hong Kong; HRCT ϭ high-resolution CT; HRQoL ϭ health-related quality of life; IQR ϭ interquartile range; Kco ϭ diffusing capacity of the lung for carbon dioxide adjusted for alveolar volume; LDH ϭ lactate dehydrogenase; LOS ϭ length of stay; MH ϭ mental health; Pemax ϭ maximum static expiratory pressure; Pimax ϭ maximum static inspiratory pressure; PF ϭ physical functioning; RE ϭ role limitation due to emotional problems; RP ϭ role limitation due to physical problems; RV ϭ residual volume; SARS ϭ severe acute respiratory syndrome; SF ϭ social functioning; SF-36 ϭ Medical Outcomes Study 36-Item Short-Form General Health Survey; TLC ϭ total lung capacity; Va ϭ alveolar volume; VC ϭ vital capacity; VT ϭ vitality; 6MWD ϭ 6-min walk distance; 6MWT ϭ 6-min walk test T he emergence of severe acute respiratory syndrome (SARS) in Southern China in November 2002, followed by the global outbreak in 2003, caught the medical profession by surprise. 1-3 Studies on SARS-coronavirus viral loads have shown that peak viral levels were reached at the second week of illness when patients were receiving hospital care, and thus health-care workers (HCWs) were particularly prone to infection while caring for their patients. 4, 5 The morbidity of SARS is highlighted by the observation that even when there was only 10% of total lung field involved by consolidation, 50% of patients would require supplemental oxygen in order

A:
The 1-Year Impact of Severe Acute Respiratory Syndrome on Pulmonary Function, Exercise Capacity, and Quality of Life in a Cohort of Survivors* *From the Center for Emerging Infectious Diseases (Drs and Tam), and Diagnostic Radiology and Organ Imaging
****